Latest Breaking News On - Investigator initiated phase - Page 1 : comparemela.com

Let’s start up with the current stock price of Onconova Therapeutics Inc. (ONTX), which is $0.66 to be very precise. The Stock rose vividly during the last session to $0.73 after opening rate of $0.7205 while the lowest price it went was recorded $0.6543 before closing at $0.72. Recently in News on April 22, 2021, Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma. Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced today that the first patient has been dosed in an investigator-initiated Phase 2 study to assess the efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa (RDEB)-associated locally advanced/metastatic squamous cell carcinoma (SCC). The patient was dosed at the EB House Austria, a center

United kingdomOnconova therapeutics incUniversity hospital salzburgOnconova therapeuticsOnconova announces first patient dosedInvestigator initiated phaseBackdoor way to profit from todayCrypto bull marketEquity ratioRaw stochasticஒன்றுபட்டது கிஂக்டம்புலனாய்வாளர் தொடங்கப்பட்டது கட்டம்பின் கதவு வழி க்கு ப்ராஃபிட் இருந்து இன்றுகிரிப்டோ காளை சந்தைபங்கு ரேஶியோ